纳米立方液晶系统作为抗肿瘤药物载体的研究进展  

Research Progress of Nano Cubic Liquid Crystal Systems as Antitumor Drug Carriers

作　　者：初明慧 纪宏宇[1,2,3] 王海荣 冯佳玉[1,2,3] 张诚诚 吴琳华 Chu Minghui;Ji Hongyu;Wang Hairong;Feng Jiayu;Zhang Chengcheng;Wu Linhua(Department of Phar- macy, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;College of Pharmacy, Harbin Medical University;Key Laboratory of Pharmacetieal Research, College of Heilongjiang Province)

机构地区：[1]哈尔滨医科大学附属第二医院药学部,哈尔滨150086 [2]哈尔滨医科大学药学院 [3]黑龙江省高校重点实验室

出　　处：《中国药师》2018年第4期710-714,共5页China Pharmacist

摘　　要：对近年来纳米立方液晶系统作为药物载体在抗肿瘤方面的研究进展进行综述。介绍纳米液晶的结构、特点、制备方法和常用材料,及其在肿瘤方面的应用。纳米立方晶具有提高药物溶解度和稳定性的优势,并具有良好的生物相容性,作为新型纳米药物载体广泛受到人们关注。The research progress in nano cubic crystal systems as drug carriers for antitumor agents in recent years was summa- rized. The structure, characteristics, preparation methods, common used materials and application of nano liquid crystals containing antitumor drugs were introduced. Nano cubic crystals showed the advantages of improving the solubility and stability of drugs and good biocompatibility that made them achieve widely attention as a new type of nano drug carriers.

关 键 词：纳米立方液晶 抗肿瘤 新型药物载体 研究进展 

分 类 号：R944.9[医药卫生—药剂学]